| Alternative Name: | Bone morphogenetic protein 4 |
| |
| MW: | Dimer, 13.1/26.2 kDa (116/232 amino acids). |
| |
| Source: | Produced in genetically modified CHO cells. |
| |
| UniProt ID: | P12644 |
| |
| Formulation: | Lyophilized from a sterile (0.2 micron) filtered aqueous solution containing 0.1% Trifluoroacetic Acid (TFA). |
| |
| Purity: | ≥95% (SDS-PAGE) |
| |
| Endotoxin Content: | ≤ 1 EU/µg |
| |
| Reconstitution: | Reconstitute in sterile water at 0.1 mg/mL. |
| |
| Shipping: | Ambient |
| |
| Long Term Storage: | -80°C |
| |
| Handling: | Avoid freeze/thaw cycles. After reconstitution, prepare aliquots and store at -80°C. For long term storage, it is recommended to dilute to working aliquots in a 0.1% BSA solution. |
| |
| Scientific Background: | Bone morphogenetic protein 4 (BMP-4) is a member of the bone morphogenetic growth factor family (BMP) and functions as a critical component in the culture and differentiation of stem cells. Active BMP-4 forms a homodimer or a heterodimer with related BMPs. BMP-4 is integral for the differentiation of mesoderm and ectoderm from pluripotent stem cells (iPSCs and ESCs) in stem cell cultures. BMP-4 is also used in culturing cardiomyocytes, early hematopoietic cells, hepatocytes, bone, cartilage, adipocytes, and lung cells, as well as inhibiting early neuronal differentiation. |
| |
| Regulatory Status: | RUO - Research Use Only |
| |
